Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Br J Cancer 2008 May 06;989:1536-9. doi: 10.1038/sj.bjc.6604341.
Show Gene links Show Anatomy links

EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.

Fukuyoshi Y , Inoue H , Kita Y , Utsunomiya T , Ishida T , Mori M .

Fusion genes have been identified as chromosomal rearrangements in certain cancers, such as leukaemia, lymphoma, and sarcoma. The EML4-ALK (EML4: echinoderm microtubule-associated-protein-like 4; ALK: anaplastic lymphoma kinase) fusion gene has been identified as an oncogene in non-small-cell lung cancer (NSCLC). This study examined the presence of this fusion transcript in gastrointestinal and breast cancers. We evaluated the expression of the EML4-ALK transcript in 104 lung cancer cases and in 645 gastrointestinal and breast cancer samples. Only one of the lung cancer samples tested positive for the EML4-ALK fusion transcript, whereas none were detected in 555 gastrointestinal and 90 breast cancer cases. Our data suggest that the EML4-ALK fusion transcript is not present in gastrointestinal or breast cancers and is specific to NSCLC.

PubMed ID: 18414414
PMC ID: PMC2391097
Article link: Br J Cancer

Article Images: [+] show captions